BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12892688)

  • 1. LH levels in women with polycystic ovarian syndrome: have modern assays made them irrelevant?
    Milsom SR; Sowter MC; Carter MA; Knox BS; Gunn AJ
    BJOG; 2003 Aug; 110(8):760-4. PubMed ID: 12892688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia.
    Banaszewska B; Spaczyński RZ; Pelesz M; Pawelczyk L
    Rocz Akad Med Bialymst; 2003; 48():131-4. PubMed ID: 14737959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum LH and FSH levels in women with polycystic ovary syndrome before and after ovarian wedge resection.
    Shterev AD; Dokumov SI
    Endocrinologie; 1982; 20(3):203-7. PubMed ID: 6815773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome.
    Cho LW; Jayagopal V; Kilpatrick ES; Holding S; Atkin SL
    Ann Clin Biochem; 2006 May; 43(Pt 3):217-9. PubMed ID: 16704758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Hsu MI; Liou TH; Liang SJ; Su HW; Wu CH; Hsu CS
    Fertil Steril; 2009 Apr; 91(4):1168-74. PubMed ID: 18325508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ovarian drilling in middle Black Sea region Turkish women with polycystic ovary syndrome having normal and high body mass indices.
    Demirturk F; Caliskan AC; Aytan H; Erkorkmaz U
    J Obstet Gynaecol Res; 2006 Oct; 32(5):507-12. PubMed ID: 16984519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of serum gonadotropin and dehydroepiandrosterone sulfate concentrations in women with polycystic ovary syndrome.
    Oei ML; Kazer RR
    J Reprod Med; 1992 Dec; 37(12):974-8. PubMed ID: 1287208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an immunoenzymometric assay (IEMA) using automated system for determination of luteinizing hormone and follicle stimulating hormone.
    Fonseca E; Mason M; Galván RE; Pascoe D; Ochoa R; Hernández M; Zárate A
    Arch Med Res; 1997; 28(1):73-7. PubMed ID: 9078591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma follicle-stimulating and luteinizing hormones and the macrosopic characteristics of the ovaries in patients with stein-leventhal syndrome. Response to LH-RH in Stein-Leventhal syndrome.
    Valkov IM; Dokumov I
    Endocrinologie; 1977; 15(1):55-8. PubMed ID: 322249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum concentration of total inhibin in polycystic ovary syndrome.
    Tsigkou A; Luisi S; De Leo V; Patton L; Gambineri A; Reis FM; Pasquali R; Petraglia F
    Fertil Steril; 2008 Nov; 90(5):1859-63. PubMed ID: 18423626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new approach in the evaluation of gonadotropins for the diagnosis of polycystic ovary syndrome.
    Manieri C; Pastorino R; Marolda AR; Musso M; Boggio G; Fornengo R; Tagliabue M; Di Bisceglie C; Camanni F
    Panminerva Med; 1995 Sep; 37(3):115-8. PubMed ID: 8869364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
    van der Westhuizen S; van der Spuy ZM
    Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression.
    Bjercke S; Fedorcsak P; Abyholm T; Storeng R; Ertzeid G; Oldereid N; Omland A; Tanbo T
    Hum Reprod; 2005 Sep; 20(9):2441-7. PubMed ID: 15919773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of unkei-to, an herbal medicine, on endocrine function and ovulation in women with high basal levels of luteinizing hormone secretion.
    Ushiroyama T; Ikeda A; Sakai M; Hosotani T; Suzuki Y; Tsubokura S; Ueki M
    J Reprod Med; 2001 May; 46(5):451-6. PubMed ID: 11396371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
    Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of synthetic gonadotropin releasing hormone on the plasma levels of FH and LSH in women with hirsutism and polycystic ovaries].
    Pjević M; Kovac T; Bujas M; Pusac R
    Jugosl Ginekol Perinatol; 1985; 25(3-4):49-52. PubMed ID: 3938829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum resistin levels in women with polycystic ovary syndrome.
    Panidis D; Koliakos G; Kourtis A; Farmakiotis D; Mouslech T; Rousso D
    Fertil Steril; 2004 Feb; 81(2):361-6. PubMed ID: 14967374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.